Edwards Lifesciences Corporation, founded in 1958, is a leading medical technology company headquartered in Irvine, California. The company focuses on providing innovative solutions for patients suffering from heart disease and related conditions. With a team of over 15,000 employees as of 2023, Edwards Lifesciences is dedicated to improving patient outcomes through advanced cardiovascular technologies.

Edwards Lifesciences is a global leader in heart valve replacement and repair therapies, as well as critical care monitoring systems. The company's products and technologies are designed to address the needs of patients with structural heart diseases and advanced surgical and interventional procedures. At Edwards Lifesciences cash, cash equivalents and short-term investments totaled $1.3 billion as of March 31, 2023.